+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Ultrasonic Microbubble Contrast Agents Market - Global Forecast 2026-2032- Product Image
Ultrasonic Microbubble Contrast Agents Market - Global Forecast 2026-2032- Product Image
Sale

Ultrasonic Microbubble Contrast Agents Market - Global Forecast 2026-2032

  • Report

  • 191 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6145850
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Ultrasonic Microbubble Contrast Agents Market is projected to reach USD 1.34 Billion in 2026. It is expected to continue growing at a CAGR of 9.30%, reaching USD 2.28 Billion by 2032.

Ultrasonic Microbubble Contrast Agents: Executive Overview

Ultrasonic microbubble contrast agents enhance ultrasound visualization by producing strong acoustic responses that improve the detection and characterization of blood flow, perfusion, and selected lesions. Their clinical relevance is tied to ultrasound’s portability, real-time imaging, absence of ionizing radiation, and expanding use in abdominal, cardiovascular, vascular, and oncology-related assessment. Adoption depends on validated clinical utility, regulatory authorization, operator expertise, reimbursement conditions, and reliable access to imaging equipment and trained personnel.

Clinical Integration Is Reshaping Contrast-Enhanced Ultrasound

The landscape is shifting from contrast agents being used primarily for specialized examinations toward broader integration into diagnostic workflows where conventional ultrasound or other imaging methods leave uncertainty. Greater emphasis on standardized protocols, image quality, safety monitoring, and reproducible interpretation is supporting more consistent clinical use. Additional change is coming from point-of-care imaging, improved transducer technology, workflow digitization, and efforts to reduce avoidable referrals or repeat examinations while preserving diagnostic confidence.

Artificial Intelligence Is Increasing the Value of Microbubble-Enhanced Imaging

Artificial intelligence is contributing to the cumulative impact of microbubble-enhanced ultrasound through automated image quality assessment, lesion detection, motion correction, perfusion quantification, and decision support. These tools can help clinicians interpret dynamic contrast behavior and reduce variability between operators, but their usefulness depends on representative training data, transparent validation, interoperability, and safeguards against automation bias. Evidence generation should therefore assess AI-enabled workflows against clinically meaningful outcomes rather than relying solely on technical performance metrics.

Regional Dynamics Reflect Uneven Access and Different Clinical Priorities

North America is characterized by established advanced-imaging infrastructure, specialist adoption, and attention to reimbursement and evidence requirements. Europe combines mature hospital systems with strong emphasis on safety, cross-border regulation, and standardized clinical practice. Asia-Pacific presents substantial diversity, with advanced adoption in countries such as Japan, South Korea, and Australia alongside capacity-building needs in other markets. Latin America is influenced by uneven access to equipment, specialist training, and public-sector funding. The Middle East is developing advanced diagnostic capacity through hospital modernization, while Africa continues to face constraints involving infrastructure, workforce availability, procurement, and maintenance. Across all regions, local clinical guidelines, regulatory pathways, and supply reliability materially affect implementation.

Economic and Political Groups Shape Procurement, Standards, and Access

ASEAN markets differ considerably in regulatory maturity, healthcare financing, and specialist availability, making regional harmonization and training particularly relevant. BRICS members span highly varied health systems and manufacturing capabilities, with access shaped by public procurement, domestic production, and urban-rural disparities. The European Union benefits from coordinated regulatory structures while retaining national differences in reimbursement and clinical adoption. G7 countries generally have advanced imaging ecosystems but face evidence, cost-effectiveness, and workforce pressures. GCC countries are investing in sophisticated hospital capacity and centralized procurement, whereas NATO members reflect a broad range of health-system maturity and may emphasize resilience, interoperability, and continuity of diagnostic services.

Country-Level Priorities Range from Innovation Leadership to Capacity Building

Australia emphasizes evidence-based imaging, rural access, and workforce distribution. Brazil and Mexico face the dual challenge of expanding advanced diagnostics while addressing regional inequality and public-sector resource constraints. Canada and the United States have sophisticated imaging capabilities, with adoption influenced by clinical evidence, reimbursement, accreditation, and specialist availability. China is strengthening domestic healthcare capacity and technology development, while India is balancing rapid urban growth with major access gaps outside metropolitan centers. Japan and South Korea have advanced ultrasound expertise and strong technology adoption. France, Germany, Italy, Spain, and the United Kingdom are shaped by established healthcare systems, regulatory compliance, budget discipline, and differing reimbursement pathways. Russia’s operating environment is influenced by healthcare modernization, supply continuity, and access to specialized technology.

Priorities for Leaders: Prove Utility, Build Capability, and Secure Access

Industry leaders should prioritize evidence that demonstrates how microbubble-enhanced ultrasound changes diagnosis, treatment planning, monitoring, or referral decisions. They should develop training programs covering patient selection, administration, image acquisition, interpretation, and adverse-event readiness, with content adapted to local practice. Partnerships with hospitals and professional societies can support protocol standardization and real-world validation. Organizations should also strengthen supply resilience, provide interoperable workflow tools, and evaluate AI features through transparent governance. Market access planning should address regulatory documentation, reimbursement evidence, procurement requirements, and equitable deployment across urban and underserved settings.

Methodology: Evidence-Led Assessment of Clinical and Operating Conditions

This executive summary uses a structured qualitative assessment of ultrasonic microbubble contrast agents across clinical adoption, technology development, healthcare infrastructure, regulation, reimbursement, workforce, procurement, and regional access conditions. The analysis organizes findings across the specified regions, economic and political groups, and countries, while distinguishing established applications from emerging opportunities. It excludes market estimates, market shares, forecasts, company-specific claims, and unsupported performance assertions. Interpretation should be updated as clinical guidelines, regulatory decisions, reimbursement policies, safety evidence, and AI validation studies evolve.

Conclusion: Sustainable Adoption Depends on Demonstrated Clinical Value

Ultrasonic microbubble contrast agents occupy an important position at the intersection of advanced ultrasound, minimally invasive diagnosis, and increasingly data-driven clinical care. Their continued adoption will depend less on technical novelty alone than on reliable evidence, skilled users, integrated workflows, responsible AI, and equitable access to equipment and expertise. Leaders that connect product development with clinical outcomes, education, regulatory readiness, and resilient delivery will be better positioned to support durable use across diverse healthcare systems.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Ultrasonic Microbubble Contrast Agents Market, by Product Type
7.1. Introduction
7.2. Multi Bubble
7.3. Single Bubble
7.4. Targeted Agent
8. Ultrasonic Microbubble Contrast Agents Market, by Application
8.1. Introduction
8.2. Cardiovascular
8.3. Gastroenterology
8.4. Oncology
8.4.1. Breast Cancer
8.4.2. Liver Cancer
8.4.3. Lung Cancer
8.5. Urology
9. Ultrasonic Microbubble Contrast Agents Market, by End User
9.1. Introduction
9.2. Clinics
9.3. Diagnostic Centers
9.4. Hospitals
9.4.1. Secondary Care
9.4.2. Tertiary Care
10. Ultrasonic Microbubble Contrast Agents Market, by Distribution Channel
10.1. Introduction
10.2. Hospital Pharmacy
10.3. Online Pharmacy
10.4. Retail Pharmacy
11. Ultrasonic Microbubble Contrast Agents Market, by Region
11.1. Introduction
11.2. Asia-Pacific
11.3. North America
11.4. Latin America
11.5. Europe
11.6. Middle East
11.7. Africa
12. Ultrasonic Microbubble Contrast Agents Market, by Group
12.1. Introduction
12.2. ASEAN
12.3. GCC
12.4. European Union
12.5. BRICS
12.6. G7
12.7. NATO
13. Ultrasonic Microbubble Contrast Agents Market, by Country
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. United Kingdom
13.7. Germany
13.8. France
13.9. Russia
13.10. Italy
13.11. Spain
13.12. China
13.13. India
13.14. Japan
13.15. Australia
13.16. South Korea
14. Competitive Landscape
14.1. Market Share Analysis, 2025
14.2. Market Concentration Analysis, 2025
14.2.1. Concentration Ratio (CR)
14.2.2. Herfindahl Hirschman Index (HHI)
14.3. Recent Developments & Impact Analysis, 2025
14.4. Product Portfolio Analysis, 2025
14.5. Benchmarking Analysis, 2025
15. Company Profiles
15.1. Advanced Microbubbles Inc.
15.2. Aspect Imaging Ltd.
15.3. BCM Technologies, Inc.
15.4. Biocell Technology LLC
15.5. Bracco Suisse SA
15.6. Canon Medical Systems Corporation
15.7. CURASIS GmbH
15.8. Daiichi Sankyo Company, Limited
15.9. Esaote SpA
15.10. Fujifilm Holdings Corporation
15.11. GE Healthcare AS
15.12. Hitachi, Ltd.
15.13. Lantheus Medical Imaging, Inc.
15.14. Mallinckrodt plc
15.15. Microbubble Therapeutics Pty Ltd
15.16. Mindray Medical International Limited
15.17. Samsung Medison Co., Ltd.
15.18. Siemens Healthineers AG
15.19. Targeson, Inc.
16. Key Experts
LIST OF FIGURES
FIGURE 1. Global Ultrasonic Microbubble Contrast Agents Market, Years Considered for the Study
FIGURE 2. Global Ultrasonic Microbubble Contrast Agents Market, Research Design
FIGURE 3. Global Ultrasonic Microbubble Contrast Agents Market, Research Framework
FIGURE 4. Global Ultrasonic Microbubble Contrast Agents Market, Data Triangulation
FIGURE 5. Global Ultrasonic Microbubble Contrast Agents Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Ultrasonic Microbubble Contrast Agents Market Size, by Product Type, 2025 vs 2032 (%)
FIGURE 7. Global Ultrasonic Microbubble Contrast Agents Market Size, by Product Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Ultrasonic Microbubble Contrast Agents Market Size, by Application, 2025 vs 2032 (%)
FIGURE 9. Global Ultrasonic Microbubble Contrast Agents Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Ultrasonic Microbubble Contrast Agents Market Size, by End User, 2025 vs 2032 (%)
FIGURE 11. Global Ultrasonic Microbubble Contrast Agents Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Ultrasonic Microbubble Contrast Agents Market Size, by Distribution Channel, 2025 vs 2032 (%)
FIGURE 13. Global Ultrasonic Microbubble Contrast Agents Market Size, by Distribution Channel, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Ultrasonic Microbubble Contrast Agents Market Size, by Region, 2025 vs 2032 (%)
FIGURE 15. Global Ultrasonic Microbubble Contrast Agents Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Ultrasonic Microbubble Contrast Agents Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 17. Global Ultrasonic Microbubble Contrast Agents Market Size, by Country, 2025 vs 2032 (%)
FIGURE 18. Global Ultrasonic Microbubble Contrast Agents Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Ultrasonic Microbubble Contrast Agents Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Ultrasonic Microbubble Contrast Agents Market Segmentation & Coverage
TABLE 2. Global Ultrasonic Microbubble Contrast Agents Market Size, 2017-2032 (USD Million)
TABLE 3. Global Ultrasonic Microbubble Contrast Agents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 4. Global Multi Bubble Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Multi Bubble Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Multi Bubble Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Single Bubble Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Single Bubble Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Single Bubble Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Targeted Agent Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Targeted Agent Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Targeted Agent Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Ultrasonic Microbubble Contrast Agents Market Size, by Application, 2017-2032 (USD Million)
TABLE 14. Global Cardiovascular Market Size, by Region, 2017-2032 (USD Million)
TABLE 15. Global Cardiovascular Market Size, by Group, 2017-2032 (USD Million)
TABLE 16. Global Cardiovascular Market Size, by Country, 2017-2032 (USD Million)
TABLE 17. Global Gastroenterology Market Size, by Region, 2017-2032 (USD Million)
TABLE 18. Global Gastroenterology Market Size, by Group, 2017-2032 (USD Million)
TABLE 19. Global Gastroenterology Market Size, by Country, 2017-2032 (USD Million)
TABLE 20. Global Oncology Market Size, by Region, 2017-2032 (USD Million)
TABLE 21. Global Oncology Market Size, by Group, 2017-2032 (USD Million)
TABLE 22. Global Oncology Market Size, by Country, 2017-2032 (USD Million)
TABLE 23. Global Breast Cancer Market Size, by Region, 2017-2032 (USD Million)
TABLE 24. Global Breast Cancer Market Size, by Group, 2017-2032 (USD Million)
TABLE 25. Global Breast Cancer Market Size, by Country, 2017-2032 (USD Million)
TABLE 26. Global Liver Cancer Market Size, by Region, 2017-2032 (USD Million)
TABLE 27. Global Liver Cancer Market Size, by Group, 2017-2032 (USD Million)
TABLE 28. Global Liver Cancer Market Size, by Country, 2017-2032 (USD Million)
TABLE 29. Global Lung Cancer Market Size, by Region, 2017-2032 (USD Million)
TABLE 30. Global Lung Cancer Market Size, by Group, 2017-2032 (USD Million)
TABLE 31. Global Lung Cancer Market Size, by Country, 2017-2032 (USD Million)
TABLE 32. Global Urology Market Size, by Region, 2017-2032 (USD Million)
TABLE 33. Global Urology Market Size, by Group, 2017-2032 (USD Million)
TABLE 34. Global Urology Market Size, by Country, 2017-2032 (USD Million)
TABLE 35. Global Ultrasonic Microbubble Contrast Agents Market Size, by End User, 2017-2032 (USD Million)
TABLE 36. Global Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 37. Global Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 38. Global Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 39. Global Diagnostic Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 40. Global Diagnostic Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 41. Global Diagnostic Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 42. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 43. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 44. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 45. Global Secondary Care Market Size, by Region, 2017-2032 (USD Million)
TABLE 46. Global Secondary Care Market Size, by Group, 2017-2032 (USD Million)
TABLE 47. Global Secondary Care Market Size, by Country, 2017-2032 (USD Million)
TABLE 48. Global Tertiary Care Market Size, by Region, 2017-2032 (USD Million)
TABLE 49. Global Tertiary Care Market Size, by Group, 2017-2032 (USD Million)
TABLE 50. Global Tertiary Care Market Size, by Country, 2017-2032 (USD Million)
TABLE 51. Global Ultrasonic Microbubble Contrast Agents Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 52. Global Hospital Pharmacy Market Size, by Region, 2017-2032 (USD Million)
TABLE 53. Global Hospital Pharmacy Market Size, by Group, 2017-2032 (USD Million)
TABLE 54. Global Hospital Pharmacy Market Size, by Country, 2017-2032 (USD Million)
TABLE 55. Global Online Pharmacy Market Size, by Region, 2017-2032 (USD Million)
TABLE 56. Global Online Pharmacy Market Size, by Group, 2017-2032 (USD Million)
TABLE 57. Global Online Pharmacy Market Size, by Country, 2017-2032 (USD Million)
TABLE 58. Global Retail Pharmacy Market Size, by Region, 2017-2032 (USD Million)
TABLE 59. Global Retail Pharmacy Market Size, by Group, 2017-2032 (USD Million)
TABLE 60. Global Retail Pharmacy Market Size, by Country, 2017-2032 (USD Million)
TABLE 61. Global Ultrasonic Microbubble Contrast Agents Market Size, by Region, 2017-2032 (USD Million)
TABLE 62. Asia-Pacific Ultrasonic Microbubble Contrast Agents Market Size, by Region, 2017-2032 (USD Million)
TABLE 63. Asia-Pacific Ultrasonic Microbubble Contrast Agents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 64. Asia-Pacific Ultrasonic Microbubble Contrast Agents Market Size, by Application, 2017-2032 (USD Million)
TABLE 65. Asia-Pacific Ultrasonic Microbubble Contrast Agents Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 66. Asia-Pacific Ultrasonic Microbubble Contrast Agents Market Size, by End User, 2017-2032 (USD Million)
TABLE 67. Asia-Pacific Ultrasonic Microbubble Contrast Agents Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 68. Asia-Pacific Ultrasonic Microbubble Contrast Agents Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 69. North America Ultrasonic Microbubble Contrast Agents Market Size, by Region, 2017-2032 (USD Million)
TABLE 70. North America Ultrasonic Microbubble Contrast Agents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 71. North America Ultrasonic Microbubble Contrast Agents Market Size, by Application, 2017-2032 (USD Million)
TABLE 72. North America Ultrasonic Microbubble Contrast Agents Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 73. North America Ultrasonic Microbubble Contrast Agents Market Size, by End User, 2017-2032 (USD Million)
TABLE 74. North America Ultrasonic Microbubble Contrast Agents Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 75. North America Ultrasonic Microbubble Contrast Agents Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 76. Latin America Ultrasonic Microbubble Contrast Agents Market Size, by Region, 2017-2032 (USD Million)
TABLE 77. Latin America Ultrasonic Microbubble Contrast Agents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 78. Latin America Ultrasonic Microbubble Contrast Agents Market Size, by Application, 2017-2032 (USD Million)
TABLE 79. Latin America Ultrasonic Microbubble Contrast Agents Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 80. Latin America Ultrasonic Microbubble Contrast Agents Market Size, by End User, 2017-2032 (USD Million)
TABLE 81. Latin America Ultrasonic Microbubble Contrast Agents Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 82. Latin America Ultrasonic Microbubble Contrast Agents Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 83. Europe Ultrasonic Microbubble Contrast Agents Market Size, by Region, 2017-2032 (USD Million)
TABLE 84. Europe Ultrasonic Microbubble Contrast Agents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 85. Europe Ultrasonic Microbubble Contrast Agents Market Size, by Application, 2017-2032 (USD Million)
TABLE 86. Europe Ultrasonic Microbubble Contrast Agents Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 87. Europe Ultrasonic Microbubble Contrast Agents Market Size, by End User, 2017-2032 (USD Million)
TABLE 88. Europe Ultrasonic Microbubble Contrast Agents Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 89. Europe Ultrasonic Microbubble Contrast Agents Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 90. Middle East Ultrasonic Microbubble Contrast Agents Market Size, by Region, 2017-2032 (USD Million)
TABLE 91. Middle East Ultrasonic Microbubble Contrast Agents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 92. Middle East Ultrasonic Microbubble Contrast Agents Market Size, by Application, 2017-2032 (USD Million)
TABLE 93. Middle East Ultrasonic Microbubble Contrast Agents Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 94. Middle East Ultrasonic Microbubble Contrast Agents Market Size, by End User, 2017-2032 (USD Million)
TABLE 95. Middle East Ultrasonic Microbubble Contrast Agents Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 96. Middle East Ultrasonic Microbubble Contrast Agents Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 97. Africa Ultrasonic Microbubble Contrast Agents Market Size, by Region, 2017-2032 (USD Million)
TABLE 98. Africa Ultrasonic Microbubble Contrast Agents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 99. Africa Ultrasonic Microbubble Contrast Agents Market Size, by Application, 2017-2032 (USD Million)
TABLE 100. Africa Ultrasonic Microbubble Contrast Agents Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 101. Africa Ultrasonic Microbubble Contrast Agents Market Size, by End User, 2017-2032 (USD Million)
TABLE 102. Africa Ultrasonic Microbubble Contrast Agents Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 103. Africa Ultrasonic Microbubble Contrast Agents Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 104. Global Ultrasonic Microbubble Contrast Agents Market Size, by Group, 2017-2032 (USD Million)
TABLE 105. ASEAN Ultrasonic Microbubble Contrast Agents Market Size, by Group, 2017-2032 (USD Million)
TABLE 106. ASEAN Ultrasonic Microbubble Contrast Agents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 107. ASEAN Ultrasonic Microbubble Contrast Agents Market Size, by Application, 2017-2032 (USD Million)
TABLE 108. ASEAN Ultrasonic Microbubble Contrast Agents Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 109. ASEAN Ultrasonic Microbubble Contrast Agents Market Size, by End User, 2017-2032 (USD Million)
TABLE 110. ASEAN Ultrasonic Microbubble Contrast Agents Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 111. ASEAN Ultrasonic Microbubble Contrast Agents Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 112. GCC Ultrasonic Microbubble Contrast Agents Market Size, by Group, 2017-2032 (USD Million)
TABLE 113. GCC Ultrasonic Microbubble Contrast Agents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 114. GCC Ultrasonic Microbubble Contrast Agents Market Size, by Application, 2017-2032 (USD Million)
TABLE 115. GCC Ultrasonic Microbubble Contrast Agents Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 116. GCC Ultrasonic Microbubble Contrast Agents Market Size, by End User, 2017-2032 (USD Million)
TABLE 117. GCC Ultrasonic Microbubble Contrast Agents Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 118. GCC Ultrasonic Microbubble Contrast Agents Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 119. European Union Ultrasonic Microbubble Contrast Agents Market Size, by Group, 2017-2032 (USD Million)
TABLE 120. European Union Ultrasonic Microbubble Contrast Agents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 121. European Union Ultrasonic Microbubble Contrast Agents Market Size, by Application, 2017-2032 (USD Million)
TABLE 122. European Union Ultrasonic Microbubble Contrast Agents Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 123. European Union Ultrasonic Microbubble Contrast Agents Market Size, by End User, 2017-2032 (USD Million)
TABLE 124. European Union Ultrasonic Microbubble Contrast Agents Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 125. European Union Ultrasonic Microbubble Contrast Agents Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 126. BRICS Ultrasonic Microbubble Contrast Agents Market Size, by Group, 2017-2032 (USD Million)
TABLE 127. BRICS Ultrasonic Microbubble Contrast Agents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 128. BRICS Ultrasonic Microbubble Contrast Agents Market Size, by Application, 2017-2032 (USD Million)
TABLE 129. BRICS Ultrasonic Microbubble Contrast Agents Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 130. BRICS Ultrasonic Microbubble Contrast Agents Market Size, by End User, 2017-2032 (USD Million)
TABLE 131. BRICS Ultrasonic Microbubble Contrast Agents Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 132. BRICS Ultrasonic Microbubble Contrast Agents Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 133. G7 Ultrasonic Microbubble Contrast Agents Market Size, by Group, 2017-2032 (USD Million)
TABLE 134. G7 Ultrasonic Microbubble Contrast Agents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 135. G7 Ultrasonic Microbubble Contrast Agents Market Size, by Application, 2017-2032 (USD Million)
TABLE 136. G7 Ultrasonic Microbubble Contrast Agents Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 137. G7 Ultrasonic Microbubble Contrast Agents Market Size, by End User, 2017-2032 (USD Million)
TABLE 138. G7 Ultrasonic Microbubble Contrast Agents Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 139. G7 Ultrasonic Microbubble Contrast Agents Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 140. NATO Ultrasonic Microbubble Contrast Agents Market Size, by Group, 2017-2032 (USD Million)
TABLE 141. NATO Ultrasonic Microbubble Contrast Agents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 142. NATO Ultrasonic Microbubble Contrast Agents Market Size, by Application, 2017-2032 (USD Million)
TABLE 143. NATO Ultrasonic Microbubble Contrast Agents Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 144. NATO Ultrasonic Microbubble Contrast Agents Market Size, by End User, 2017-2032 (USD Million)
TABLE 145. NATO Ultrasonic Microbubble Contrast Agents Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 146. NATO Ultrasonic Microbubble Contrast Agents Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 147. Global Ultrasonic Microbubble Contrast Agents Market Size, by Country, 2017-2032 (USD Million)
TABLE 148. United States Ultrasonic Microbubble Contrast Agents Market Size, 2017-2032 (USD Million)
TABLE 149. United States Ultrasonic Microbubble Contrast Agents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 150. United States Ultrasonic Microbubble Contrast Agents Market Size, by Application, 2017-2032 (USD Million)
TABLE 151. United States Ultrasonic Microbubble Contrast Agents Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 152. United States Ultrasonic Microbubble Contrast Agents Market Size, by End User, 2017-2032 (USD Million)
TABLE 153. United States Ultrasonic Microbubble Contrast Agents Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 154. United States Ultrasonic Microbubble Contrast Agents Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 155. Canada Ultrasonic Microbubble Contrast Agents Market Size, 2017-2032 (USD Million)
TABLE 156. Canada Ultrasonic Microbubble Contrast Agents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 157. Canada Ultrasonic Microbubble Contrast Agents Market Size, by Application, 2017-2032 (USD Million)
TABLE 158. Canada Ultrasonic Microbubble Contrast Agents Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 159. Canada Ultrasonic Microbubble Contrast Agents Market Size, by End User, 2017-2032 (USD Million)
TABLE 160. Canada Ultrasonic Microbubble Contrast Agents Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 161. Canada Ultrasonic Microbubble Contrast Agents Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 162. Mexico Ultrasonic Microbubble Contrast Agents Market Size, 2017-2032 (USD Million)
TABLE 163. Mexico Ultrasonic Microbubble Contrast Agents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 164. Mexico Ultrasonic Microbubble Contrast Agents Market Size, by Application, 2017-2032 (USD Million)
TABLE 165. Mexico Ultrasonic Microbubble Contrast Agents Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 166. Mexico Ultrasonic Microbubble Contrast Agents Market Size, by End User, 2017-2032 (USD Million)
TABLE 167. Mexico Ultrasonic Microbubble Contrast Agents Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 168. Mexico Ultrasonic Microbubble Contrast Agents Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 169. Brazil Ultrasonic Microbubble Contrast Agents Market Size, 2017-2032 (USD Million)
TABLE 170. Brazil Ultrasonic Microbubble Contrast Agents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 171. Brazil Ultrasonic Microbubble Contrast Agents Market Size, by Application, 2017-2032 (USD Million)
TABLE 172. Brazil Ultrasonic Microbubble Contrast Agents Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 173. Brazil Ultrasonic Microbubble Contrast Agents Market Size, by End User, 2017-2032 (USD Million)
TABLE 174. Brazil Ultrasonic Microbubble Contrast Agents Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 175. Brazil Ultrasonic Microbubble Contrast Agents Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 176. United Kingdom Ultrasonic Microbubble Contrast Agents Market Size, 2017-2032 (USD Million)
TABLE 177. United Kingdom Ultrasonic Microbubble Contrast Agents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 178. United Kingdom Ultrasonic Microbubble Contrast Agents Market Size, by Application, 2017-2032 (USD Million)
TABLE 179. United Kingdom Ultrasonic Microbubble Contrast Agents Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 180. United Kingdom Ultrasonic Microbubble Contrast Agents Market Size, by End User, 2017-2032 (USD Million)
TABLE 181. United Kingdom Ultrasonic Microbubble Contrast Agents Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 182. United Kingdom Ultrasonic Microbubble Contrast Agents Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 183. Germany Ultrasonic Microbubble Contrast Agents Market Size, 2017-2032 (USD Million)
TABLE 184. Germany Ultrasonic Microbubble Contrast Agents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 185. Germany Ultrasonic Microbubble Contrast Agents Market Size, by Application, 2017-2032 (USD Million)
TABLE 186. Germany Ultrasonic Microbubble Contrast Agents Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 187. Germany Ultrasonic Microbubble Contrast Agents Market Size, by End User, 2017-2032 (USD Million)
TABLE 188. Germany Ultrasonic Microbubble Contrast Agents Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 189. Germany Ultrasonic Microbubble Contrast Agents Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 190. France Ultrasonic Microbubble Contrast Agents Market Size, 2017-2032 (USD Million)
TABLE 191. France Ultrasonic Microbubble Contrast Agents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 192. France Ultrasonic Microbubble Contrast Agents Market Size, by Application, 2017-2032 (USD Million)
TABLE 193. France Ultrasonic Microbubble Contrast Agents Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 194. France Ultrasonic Microbubble Contrast Agents Market Size, by End User, 2017-2032 (USD Million)
TABLE 195. France Ultrasonic Microbubble Contrast Agents Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 196. France Ultrasonic Microbubble Contrast Agents Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 197. Russia Ultrasonic Microbubble Contrast Agents Market Size, 2017-2032 (USD Million)
TABLE 198. Russia Ultrasonic Microbubble Contrast Agents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 199. Russia Ultrasonic Microbubble Contrast Agents Market Size, by Application, 2017-2032 (USD Million)
TABLE 200. Russia Ultrasonic Microbubble Contrast Agents Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 201. Russia Ultrasonic Microbubble Contrast Agents Market Size, by End User, 2017-2032 (USD Million)
TABLE 202. Russia Ultrasonic Microbubble Contrast Agents Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 203. Russia Ultrasonic Microbubble Contrast Agents Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 204. Italy Ultrasonic Microbubble Contrast Agents Market Size, 2017-2032 (USD Million)
TABLE 205. Italy Ultrasonic Microbubble Contrast Agents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 206. Italy Ultrasonic Microbubble Contrast Agents Market Size, by Application, 2017-2032 (USD Million)
TABLE 207. Italy Ultrasonic Microbubble Contrast Agents Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 208. Italy Ultrasonic Microbubble Contrast Agents Market Size, by End User, 2017-2032 (USD Million)
TABLE 209. Italy Ultrasonic Microbubble Contrast Agents Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 210. Italy Ultrasonic Microbubble Contrast Agents Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 211. Spain Ultrasonic Microbubble Contrast Agents Market Size, 2017-2032 (USD Million)
TABLE 212. Spain Ultrasonic Microbubble Contrast Agents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 213. Spain Ultrasonic Microbubble Contrast Agents Market Size, by Application, 2017-2032 (USD Million)
TABLE 214. Spain Ultrasonic Microbubble Contrast Agents Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 215. Spain Ultrasonic Microbubble Contrast Agents Market Size, by End User, 2017-2032 (USD Million)
TABLE 216. Spain Ultrasonic Microbubble Contrast Agents Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 217. Spain Ultrasonic Microbubble Contrast Agents Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 218. China Ultrasonic Microbubble Contrast Agents Market Size, 2017-2032 (USD Million)
TABLE 219. China Ultrasonic Microbubble Contrast Agents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 220. China Ultrasonic Microbubble Contrast Agents Market Size, by Application, 2017-2032 (USD Million)
TABLE 221. China Ultrasonic Microbubble Contrast Agents Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 222. China Ultrasonic Microbubble Contrast Agents Market Size, by End User, 2017-2032 (USD Million)
TABLE 223. China Ultrasonic Microbubble Contrast Agents Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 224. China Ultrasonic Microbubble Contrast Agents Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 225. India Ultrasonic Microbubble Contrast Agents Market Size, 2017-2032 (USD Million)
TABLE 226. India Ultrasonic Microbubble Contrast Agents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 227. India Ultrasonic Microbubble Contrast Agents Market Size, by Application, 2017-2032 (USD Million)
TABLE 228. India Ultrasonic Microbubble Contrast Agents Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 229. India Ultrasonic Microbubble Contrast Agents Market Size, by End User, 2017-2032 (USD Million)
TABLE 230. India Ultrasonic Microbubble Contrast Agents Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 231. India Ultrasonic Microbubble Contrast Agents Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 232. Japan Ultrasonic Microbubble Contrast Agents Market Size, 2017-2032 (USD Million)
TABLE 233. Japan Ultrasonic Microbubble Contrast Agents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 234. Japan Ultrasonic Microbubble Contrast Agents Market Size, by Application, 2017-2032 (USD Million)
TABLE 235. Japan Ultrasonic Microbubble Contrast Agents Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 236. Japan Ultrasonic Microbubble Contrast Agents Market Size, by End User, 2017-2032 (USD Million)
TABLE 237. Japan Ultrasonic Microbubble Contrast Agents Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 238. Japan Ultrasonic Microbubble Contrast Agents Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 239. Australia Ultrasonic Microbubble Contrast Agents Market Size, 2017-2032 (USD Million)
TABLE 240. Australia Ultrasonic Microbubble Contrast Agents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 241. Australia Ultrasonic Microbubble Contrast Agents Market Size, by Application, 2017-2032 (USD Million)
TABLE 242. Australia Ultrasonic Microbubble Contrast Agents Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 243. Australia Ultrasonic Microbubble Contrast Agents Market Size, by End User, 2017-2032 (USD Million)
TABLE 244. Australia Ultrasonic Microbubble Contrast Agents Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 245. Australia Ultrasonic Microbubble Contrast Agents Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 246. South Korea Ultrasonic Microbubble Contrast Agents Market Size, 2017-2032 (USD Million)
TABLE 247. South Korea Ultrasonic Microbubble Contrast Agents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 248. South Korea Ultrasonic Microbubble Contrast Agents Market Size, by Application, 2017-2032 (USD Million)
TABLE 249. South Korea Ultrasonic Microbubble Contrast Agents Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 250. South Korea Ultrasonic Microbubble Contrast Agents Market Size, by End User, 2017-2032 (USD Million)
TABLE 251. South Korea Ultrasonic Microbubble Contrast Agents Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 252. South Korea Ultrasonic Microbubble Contrast Agents Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 253. Global Ultrasonic Microbubble Contrast Agents Market Share, by Key Player, 2025
TABLE 254. Global Ultrasonic Microbubble Contrast Agents Market, Key Experts

Companies Mentioned

  • Advanced Microbubbles Inc.
  • Aspect Imaging Ltd.
  • BCM Technologies, Inc.
  • Biocell Technology LLC
  • Bracco Suisse SA
  • Canon Medical Systems Corporation
  • CURASIS GmbH
  • Daiichi Sankyo Company, Limited
  • Esaote SpA
  • Fujifilm Holdings Corporation
  • GE Healthcare AS
  • Hitachi, Ltd.
  • Lantheus Medical Imaging, Inc.
  • Mallinckrodt plc
  • Microbubble Therapeutics Pty Ltd
  • Mindray Medical International Limited
  • Samsung Medison Co., Ltd.
  • Siemens Healthineers AG
  • Targeson, Inc.

Related Topics

Related Reports

Lipid Microbubble Ultrasound Contrast Agent Market - Global Forecast 2026-2032 - Product Image

Lipid Microbubble Ultrasound Contrast Agent Market - Global Forecast 2026-2032

  • Report
  • 198 Pages
  • Global
From
Sulfur Hexafluoride Microbubbles for Injection Market - Global Forecast 2026-2032 - Product Image

Sulfur Hexafluoride Microbubbles for Injection Market - Global Forecast 2026-2032

  • Report
  • 186 Pages
  • Global
From
Peripheral Vascular Imaging Contrast Media Market Size, Share & Trends Analysis Report by Modality (CT/ X-ray, Ultrasound), Product (Iodinated Contrast Media, Microbubble), End-use and Region with Growth Forecasts, 2025-2033 - Product Image

Peripheral Vascular Imaging Contrast Media Market Size, Share & Trends Analysis Report by Modality (CT/ X-ray, Ultrasound), Product (Iodinated Contrast Media, Microbubble), End-use and Region with Growth Forecasts, 2025-2033

  • Report
  • 120 Pages
  • Global
From
Contrast Media - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Image

Contrast Media - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • 180 Pages
  • Global
From
Contrast Media - Global Strategic Business Report - Product Image

Contrast Media - Global Strategic Business Report

  • Report
  • 513 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.